Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Agfa Healthcare
Ampronix

Stereotactic Body Radiotherapy More Convenient, Perhaps Riskier Prostate Cancer Treatment

By Medimaging International staff writers
Posted on 26 Mar 2014
A more rapid and less expensive form of radiotherapy for treating prostate cancer may come with a higher risk of urinary complications.

The standard external beam radiation therapy for prostate cancer is termed intensity-modulated radiation therapy (IMRT). SBRT is a newer treatment that delivers a greater dose of radiation per treatment than IMRT. Patients, as a result, receiving SBRT can finish a complete course of treatment in one to two weeks, compared to seven to nine weeks for IMRT. There have been few studies comparing the costs of these treatments, and their toxicity.

This new study, conducted by Yale School of Medicine (New Haven, CT, USA) investigators, published their findings online on March 10, 2014, in the Journal of Clinical Oncology. The researchers, from the Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center at Yale Cancer Center, compared IMRT to SBRT in a national sample of 4,005 Medicare patients age 66 and older receiving prostate cancer treatment. Participants received either SBRT or IMRT as a principal treatment for prostate cancer during 2008 to 2011.

“All the reports we have about the toxicity of SBRT comes from pioneering institutions,” said first author James Yu, MD, assistant professor of therapeutic radiology at Yale Cancer Center. “But now that SBRT is being used nationally, it is important to determine the costs and complications on a national level.”

Dr. Yu, senior author Cary Gross, MD, and their colleagues found that the mean per-patient cost to Medicare for a course of SBRT was about US USD 13,600, compared to USD 21,000 for IMRT. The investigators discovered that at 24 months after the initiation of the treatment, there were increased side effects for SBRT compared to IMRT, due to urethral irritation, urinary incontinence, and obstruction. Even when including the cost of treating complications, however, the overall medical costs due to SBRT were still lower than that of IMRT.

“While these data are by no means definitive, our findings emphasize the need to carefully assess the impact of new cancer treatment technologies in actual practice,” concluded Dr. Gross, professor of internal medicine at Yale School of Medicine, and director of the Yale COPPER Center at Yale Cancer Center.

Related Links:

Yale School of Medicine



Channels

MRI

view channel
Image: The ischemic penumbra is visible in some patients up to 24 hour after stroke by MRI scanning. Perfusion-weighted imaging can be used to show areas of ischemia and can be compared with the ischemic core, visible by diffusion-weighted imaging (Photo courtesy of sharinginginhealth dot ca, an open access training in healthcare resource).

Diffusion-Weighted MRI Becoming Major Tool to Diagnose Patients with Transient Ischemic Attacks

With the development of brain imaging, including cranial computed tomography (CCT), and particularly diffusion-weighted imaging-magnetic resonance imaging (DWI-MRI), the diagnosis of transient ischemic... Read more

Ultrasound

view channel
Image: Ultrasound image of the Circle of Willis (Photo courtesy of the Swedish Cerebrovascular Center, Seattle, WA, USA).

New Approaches for Transcanial Ultrasound Used for the Treatment of Brain Tumors and Targeted Drug Delivery

A study completed by a Finnish researcher provides new insights into the limitations and potential new directions for the future advancement of transcranial ultrasound therapy. Active research is ongoing... Read more

Nuclear medicine

view channel

PET/CT Using FDG-Labeled Leukocytes Detects Infection in Acute Pancreatitis Patients

A study out of India that identifies infection in patients with pancreatic fluid collections may rapidly and effectively rule out active infection in the body. This treatment may help in making nuclear medicine imaging a mainstay in clinical management practices. Acute pancreatitis (AP) is an abrupt inflammation of the pancreas.... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.